Improved overall survival in dual compared to single immune checkpoint inhibitors in BRAF V600-negative advanced melanoma.
Adi KartoloCynthia YeungMarkus KuksisWilma HopmanTara BaetzPublished in: Melanoma management (2022)
V600 wild-type advanced melanoma patients.